Literature DB >> 27512472

Coronary artery disease secondary to familial hypercholesterolaemia: An infrequent cause of increasingly common pregnancy co-morbidity.

Nicla A Varnier1, Franzisca Pettit2, David Rees3, Steven Thou1, Mark Brown2, Amanda Henry4.   

Abstract

BACKGROUND: Cardiovascular disease affects 0.2-4% of pregnancies. Coupled with the physiological stress of pregnancy, cardiovascular disease may present significant management challenges including appropriate risk:benefit analysis of medical and surgical management options. CASE: A 33-year-old gravida 4 para 1 miscarriage 2 presented at 18 weeks' gestation to the high-risk pregnancy service with a history of coronary artery disease and homozygous familial hypercholesterolaemia. Pre-pregnancy echocardiogram showed probable aortic xanthoma and preserved cardiac function. Prior to planned interventional cardiology assessment for her coronary artery disease she became pregnant, taking aspirin and multivitamins only. She had exertional angina responsive to metoprolol, agreed to recommencing statin therapy when serum cholesterol worsened, but declined angiography during pregnancy. At 36 weeks' gestation, she had further angina symptoms but no acute coronary syndrome. Induction in the High Dependency Unit with elective assisted vaginal delivery of a healthy female infant (birthweight 2460 g) occurred at 37 weeks. She underwent triple-vessel coronary artery bypass postpartum, recovering well.
CONCLUSION: Whilst this specific condition is rare, the increase in cardiovascular disease and cardiovascular risks in the obstetric population emphasises the need for clear, multidisciplinary management from the outset of pregnancy for these women.

Entities:  

Keywords:  Cardiology; cardiovascular; drugs (medication); general medicine; high-risk pregnancy

Year:  2015        PMID: 27512472      PMCID: PMC4935017          DOI: 10.1177/1753495X15593451

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  8 in total

Review 1.  Statins: mechanism of action and effects.

Authors:  C Stancu; A Sima
Journal:  J Cell Mol Med       Date:  2001 Oct-Dec       Impact factor: 5.310

2.  Familial hypercholesterolaemia.

Authors:  A David Marais
Journal:  Clin Biochem Rev       Date:  2004-02

3.  Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits.

Authors:  W Palinski; F P D'Armiento; J L Witztum; F de Nigris; F Casanada; M Condorelli; M Silvestre; C Napoli
Journal:  Circ Res       Date:  2001-11-23       Impact factor: 17.367

4.  Cardiopulmonary bypass during pregnancy.

Authors:  Anitha S John; Fionnuala Gurley; Hartzell V Schaff; Carole A Warnes; Sabrina D Phillips; Katherine W Arendt; Martin D Abel; Carl H Rose; Heidi M Connolly
Journal:  Ann Thorac Surg       Date:  2011-04       Impact factor: 4.330

Review 5.  Statin use during pregnancy: a systematic review and meta-analysis.

Authors:  D Meeike Kusters; Hajar Hassani Lahsinoui; Joris A M van de Post; Albert Wiegman; Frits A Wijburg; John J P Kastelein; Barbara A Hutten
Journal:  Expert Rev Cardiovasc Ther       Date:  2012-03

6.  ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC).

Authors:  Vera Regitz-Zagrosek; Carina Blomstrom Lundqvist; Claudio Borghi; Renata Cifkova; Rafael Ferreira; Jean-Michel Foidart; J Simon R Gibbs; Christa Gohlke-Baerwolf; Bulent Gorenek; Bernard Iung; Mike Kirby; Angela H E M Maas; Joao Morais; Petros Nihoyannopoulos; Petronella G Pieper; Patrizia Presbitero; Jolien W Roos-Hesselink; Maria Schaufelberger; Ute Seeland; Lucia Torracca
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

Review 7.  Pregnancy in women suffering from familial hypercholesterolemia: a harmful period for both mother and newborn?

Authors:  Hans J Avis; Barbara A Hutten; Marcel Th B Twickler; John J P Kastelein; Joris A M van der Post; Anton F Stalenhoef; Maud N Vissers
Journal:  Curr Opin Lipidol       Date:  2009-12       Impact factor: 4.776

8.  Statins and congenital malformations: cohort study.

Authors:  Brian T Bateman; Sonia Hernandez-Diaz; Michael A Fischer; Ellen W Seely; Jeffrey L Ecker; Jessica M Franklin; Rishi J Desai; Cora Allen-Coleman; Helen Mogun; Jerry Avorn; Krista F Huybrechts
Journal:  BMJ       Date:  2015-03-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.